Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LESW plus Intravesical Botox for Refractory Interstitial Cystitis
NCT05275647Phase 2Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- May 2021
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in interstitial cystitis (IC) (2 arms), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoints: O'Leary-Sant Symptom Score at 3 months and Incidence of Treatment-Emergent Adverse Events at 3 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT05275647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05275647.